These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 24998605)

  • 1. The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children.
    Wang B; Haji Ali Afzali H; Marshall H
    Vaccine; 2014 Aug; 32(37):4791-8. PubMed ID: 24998605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of surviving meningococcal disease in Spain: evaluation for two cases of severe meningitis and septicaemia.
    Darbà J; Kaskens L; Hark M; Wright C
    Vaccine; 2014 Sep; 32(39):5006-12. PubMed ID: 25045813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing meningococcal disease in the United States: Hospital case characteristics and costs by age.
    O'Brien JA; Caro JJ; Getsios D
    Value Health; 2006; 9(4):236-43. PubMed ID: 16903993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.
    Stoof SP; Rodenburg GD; Knol MJ; Rümke LW; Bovenkerk S; Berbers GA; Spanjaard L; van der Ende A; Sanders EA
    Clin Infect Dis; 2015 Oct; 61(8):1281-92. PubMed ID: 26123933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequelae at Hospital Discharge in 61 Children With Invasive Meningococcal Disease, Chile, 2009-2019.
    Arteta-Acosta C; Villena Martínez R; Santolaya de Pablo ME
    Pediatr Infect Dis J; 2022 Aug; 41(8):607-613. PubMed ID: 35421054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.
    Martin NG; Sadarangani M; Pollard AJ; Goldacre MJ
    Lancet Infect Dis; 2014 May; 14(5):397-405. PubMed ID: 24631222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost impact of complications in meningococcal disease: evidence from a United States managed care population.
    Davis KL; Misurski D; Miller J; Karve S
    Hum Vaccin; 2011 Apr; 7(4):458-65. PubMed ID: 21795848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study.
    Viner RM; Booy R; Johnson H; Edmunds WJ; Hudson L; Bedford H; Kaczmarski E; Rajput K; Ramsay M; Christie D
    Lancet Neurol; 2012 Sep; 11(9):774-83. PubMed ID: 22863608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic burden of invasive meningococcal disease: Evidence from a large German claims database.
    Huang L; Heuer OD; Janßen S; Häckl D; Schmedt N
    PLoS One; 2020; 15(1):e0228020. PubMed ID: 31990941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of Invasive Meningococcal Disease: A Global Systematic Review.
    Wang B; Santoreneos R; Afzali H; Giles L; Marshall H
    Pharmacoeconomics; 2018 Oct; 36(10):1201-1222. PubMed ID: 29948965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical burden and predictors of sequelae following invasive meningococcal disease in Australian children.
    Wang B; Clarke M; Thomas N; Howell S; Afzali HH; Marshall H
    Pediatr Infect Dis J; 2014 Mar; 33(3):316-8. PubMed ID: 24030352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany.
    Scholz S; Koerber F; Meszaros K; Fassbender RM; Ultsch B; Welte RR; Greiner W
    Vaccine; 2019 Mar; 37(12):1692-1701. PubMed ID: 30661834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital costs, length of stay and mortality associated with childhood, adolescent and young adult meningococcal disease in the US.
    Davis KL; Bell TJ; Miller JM; Misurski DA; Bapat B
    Appl Health Econ Health Policy; 2011 May; 9(3):197-207. PubMed ID: 21506625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease.
    Scholz S; Schwarz M; Beck E; Meszaros K; Schneider M; Ultsch B; Greiner W
    Infect Dis Ther; 2022 Feb; 11(1):367-387. PubMed ID: 34877641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
    Berry EA; Heaton PT; Kelton CM
    J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of illness of invasive meningococcal disease caused by serogroup B Neisseria meningitidis in Spain.
    Ivanova-Markova Y; González-Domínguez A; Hidalgo A; Sánchez R; García-Agua N; García-Ruiz AJ; Amanda Vallejo-Aparicio L; García A; Rodriguez R; de Gomensoro E; Gonzalez-Inchausti MDC; Shen J; Begum N; Tafalla M
    Vaccine; 2021 Dec; 39(52):7646-7654. PubMed ID: 34794819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: Linkage analysis of multiple national databases.
    Edge C; Waight P; Ribeiro S; Borrow R; Ramsay M; Ladhani S
    J Infect; 2016 Nov; 73(5):427-436. PubMed ID: 27475788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for death from meningococcal infection in Recife, Brazil.
    Duarte MC; Amorim MR; Cuevas LE; Cabral-Filho JE; Correia JB
    J Trop Pediatr; 2005 Aug; 51(4):227-31. PubMed ID: 16000346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The costs associated with the public health management of a cluster of meningococcal infection in England.
    Letouze D; Yao G; Clarke SC
    Vaccine; 2014 Sep; 32(43):5549-51. PubMed ID: 25173479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of invasive meningococcal disease in the Netherlands, 2011-2020.
    Middeldorp M; Steens A; Lagerweij G; van Sorge NM; Freudenburg-de Graaf W; A M Sanders E; de Melker HE; Knol MJ
    Vaccine; 2023 Apr; 41(16):2664-2670. PubMed ID: 36933982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.